A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: Oxidative stress-induced extracellular signal-regulated kinase activation without NF-κB inhibition

Journal of Immunology

Volumn 168, Issue 10, 2002, Pages 5318-5325

  Bureau, Fabrice ^a   Desmet, Christophe ^a   Mélotte, Dorothée ^a   Jaspar, Fabrice ^a   Volanti, Cédric ^a   Vanderplasschen, Alain ^a   Pastoret, Paul Pierre ^a   Piette, Jacques ^a   Lekeux, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTENONE; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL OBSERVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME INHIBITION; EXUDATE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATION; INHIBITION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0037093959     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.10.5318     Document Type: Article

References (51)

1. Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
2. 2 in vitro and in vivo
3. 2: Anti-tumour and anti-viral activities and the mechanisms involved
4. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells: Evidence for a transcriptional block
5. Antiviral activity of cyclopentenone prostanoids
6. Inducible cyclooxygenase may have anti-inflammatory properties
7. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist
8. 2 is a ligand for the adipocyte determination factor PPARγ
9. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
10. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
11. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress
12. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils
13. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells
14. Lipoxin A4 inhibits IL-1β-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases
15. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
16. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages
17. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
18. PPARγ agonists inhibit production of monocyte inflammatory cytokines
19. Role of cyclopentenone prostaglandins in rat carrageenin pleurisy
20. Inhibition of nuclear factor κB by prostaglandin A1: An effect associated with heat shock transcription factor activation
21. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
22. 2 in activated murine macrophages
23. 2 inhibits multiple steps in the NF-κB signaling pathway
24. Activators and target genes of Rel/NF-κB transcription factors
25. Inhibition of NF-κB/ Rel induces apoptosis of murine B cells
26. NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro
27. Inhibition of NF-κB activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3
28. Macrophages require constitutive NF-κB activation to maintain A1 expression and nutochondrial homeostasis
29. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
30. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice
31. 2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit
32. Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma
33. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
34. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
35. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo: A role for granulocyte/macrophage colony-stimulating factor
36. Multiple epithelial cell-derived factors enhance neutrophil survival: Regulation by glucocorticoids and tumor necrosis factor-α
37. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats
38. Requirement of a reactive α, β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins
39. 2
40. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation
41. 2
42. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6
43. Regulation of interleukin-5 and granulocyte-macrophage colony-stimulating factor expression
44. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway
45. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production
46. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
47. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways
48. Differential role of tyrosine phosphorylation in adhesion-induced transcription, mRNA stability, and cytoskeletal organization in human monocytes
49. 2 and a peroxisome proliferator-activated receptor γ agonist on macrophage activation
50. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARγ
51. Macrophages in human atheroma contain PPARγ: Differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro